Tumor immunophenotype and cytology results
. | CSF flow cytometry . | . | . | . | . | ||
---|---|---|---|---|---|---|---|
Case no. . | Lymphocytes per milliliter . | Tumor cells, % . | Immunophenotype . | Tumor immunohistochemistry . | Cytology . | ||
1 | 236 320 | 99 | CD20+, CD10+, κ+, λ- | Gastric biopsy: CD20+, CD10+ | Positive | ||
2 | 555 | 19 | CD19+, CD20+, λ+, κ- | Kidney biopsy: CD20+, CD10- | Rare atypical cells | ||
3 | 2500 | 0.20 | CD20+, κ+, λ- | Liver biopsy: none available | Negative | ||
4 | 800 | 7 | CD45+, κ+, λ- | Bone marrow: CD20+, CD10+ | Negative | ||
Flow cytometry: CD20+, CD10+, κ+ | |||||||
5 | <850 | 7 | CD19+, CD22+, CD45+, λ+, κ- | Liver biopsy: CD20+, CD10+ | Nondiagnostic | ||
6 | None available | 1 | CD20+, CD22+, λ+, κ- | Lymph node biopsy: CD19+, CD20+, CD10+, λ+, κ- | Negative | ||
7 | 3000 | 7 | CD20+, λ+, κ- | Intestinal biopsy: CD20+, CD30+ | Negative | ||
8 | 3125 | 13 | CD19+, CD22+, CD20-, κ-, λ-, surface IgG- | Lymph node biopsy: CD20+, C30-, CD10- | Negative | ||
9 | 1500 | 2 | CD19+, λ+, κ- | Bone marrow: CD19+, CD20+, λ+, κ- | Negative | ||
10 | 2000 | 1.94 | CD20+, λ+, κ- | Lymph node biopsy: none available (Burkitt) | Negative | ||
11 | 5750 | 4 | CD19+, CD22+, CD14-, CD45+, λ-, κ-, surface IgG- | Parotid gland: CD20+, CD10+ | Negative with lymphocytosis | ||
12 | None available | 6 | CD20+, CD22+, κ+, λ- | Subcutaneous tissue biopsy: CD20+, CD10+, κ+ | Suspicious | ||
13 | 700 | 3 | K+, λ- | Gastric biopsy: CD20+, CD45+ | Negative | ||
14 | 124 000 | 45 | CD45+, CD20-, κ-, λ- | Soft tissue biopsy: CD20+, CD10+, κ+ | Positive |
. | CSF flow cytometry . | . | . | . | . | ||
---|---|---|---|---|---|---|---|
Case no. . | Lymphocytes per milliliter . | Tumor cells, % . | Immunophenotype . | Tumor immunohistochemistry . | Cytology . | ||
1 | 236 320 | 99 | CD20+, CD10+, κ+, λ- | Gastric biopsy: CD20+, CD10+ | Positive | ||
2 | 555 | 19 | CD19+, CD20+, λ+, κ- | Kidney biopsy: CD20+, CD10- | Rare atypical cells | ||
3 | 2500 | 0.20 | CD20+, κ+, λ- | Liver biopsy: none available | Negative | ||
4 | 800 | 7 | CD45+, κ+, λ- | Bone marrow: CD20+, CD10+ | Negative | ||
Flow cytometry: CD20+, CD10+, κ+ | |||||||
5 | <850 | 7 | CD19+, CD22+, CD45+, λ+, κ- | Liver biopsy: CD20+, CD10+ | Nondiagnostic | ||
6 | None available | 1 | CD20+, CD22+, λ+, κ- | Lymph node biopsy: CD19+, CD20+, CD10+, λ+, κ- | Negative | ||
7 | 3000 | 7 | CD20+, λ+, κ- | Intestinal biopsy: CD20+, CD30+ | Negative | ||
8 | 3125 | 13 | CD19+, CD22+, CD20-, κ-, λ-, surface IgG- | Lymph node biopsy: CD20+, C30-, CD10- | Negative | ||
9 | 1500 | 2 | CD19+, λ+, κ- | Bone marrow: CD19+, CD20+, λ+, κ- | Negative | ||
10 | 2000 | 1.94 | CD20+, λ+, κ- | Lymph node biopsy: none available (Burkitt) | Negative | ||
11 | 5750 | 4 | CD19+, CD22+, CD14-, CD45+, λ-, κ-, surface IgG- | Parotid gland: CD20+, CD10+ | Negative with lymphocytosis | ||
12 | None available | 6 | CD20+, CD22+, κ+, λ- | Subcutaneous tissue biopsy: CD20+, CD10+, κ+ | Suspicious | ||
13 | 700 | 3 | K+, λ- | Gastric biopsy: CD20+, CD45+ | Negative | ||
14 | 124 000 | 45 | CD45+, CD20-, κ-, λ- | Soft tissue biopsy: CD20+, CD10+, κ+ | Positive |